Rijnstate — Arnhem, Gelderland

Public research footprint of Rijnstate, compiled from the ClinicalTrials.gov public registry.

506

Registered studies

163

Active

Recruiting now

232

Completed

Stopped or withdrawn

Most-studied conditions

Obesity · Female Urogenital Diseases and Pregnancy Complications · Triple Negative Breast Neoplasms · Acute Myeloid Leukemia, Adult

Recently updated registry entries

NCT06652438 — Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or… (Recruiting)
NCT06191744 — Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral… (Active Not Recruiting)
NCT06841354 — A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Rijnstate?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.